Anti‐tumour activity of interferon‐alpha in multiple myeloma: role of interleukin 6 and tumor cell differentiation

E-ISSN： 1365-2141|121|2|251-258

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.121, Iss.2, 2003-04, pp. : 251-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-6-Mediated Cell Growth in Multiple Myeloma – a Role for Viscum album Extracts?

Oncology Research and Treatment, Vol. 28, Iss. 8-9, 2005-08 ,pp. : 387-387

Karger

Access to resources Recommend Favorite

An Outpatient Phase II Study of Subcutaneous Interleukin-2 and Interferon-Alpha-2b in Combination with Intravenous Vinblastine in Metastatic Renal Cell Cancer

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 10-15

Karger

Access to resources Recommend Favorite

Sensitivity to Interferon-Alpha and Interferon-Stimulated Gene Factor 3 Binding Activity in Human Chronic Myelogenous Leukemia Cell Line KT-1

Acta Haematologica, Vol. 104, Iss. 1, 2000-11 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Entinostat, a novel histone deacetylase inhibitor is active in B‐cell lymphoma and enhances the anti‐tumour activity of rituximab and chemotherapy agents

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 4, 2015-05 ,pp. : 506-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 162, Iss. 2, 2013-07 ,pp. : 210-220

John Wiley & Sons Inc

Access to resources Recommend Favorite